Full Text
Anti-PD1 Drugs- Are The Reimbursed Indications Of The Marketing Authorization Respected?

Abstract

Authors

C Therasse P Paubel A Cordonnier I Fusier

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×